Insights
Expert analysis and innovative thinking on the big issues in health analytics and life sciences.
Spotlight on our latest thinking
A selection of external publications
-
Ten-year progression of obesity-related complications in a population with overweight and obesity in the UK: A retrospective open cohort study
Read on Diabetes, Obesity and Metabolism -
Variations in healthcare costs by body mass index and obesity-related complications in a UK population: A retrospective open cohort study
Read on Diabetes, Obesity and Metabolism -
-
The expanding landscape of digital health and real-world evidence in pharmacoepidemiology: reflections from ISPE 2024
Read on The Evidence Base -
Weekly variation in health-care quality by day and time of admission: a nationwide, registry-based, prospective cohort study of acute stroke care
Read on The Lancet -
A systematic review of machine learning models for predicting outcomes of stroke with structured data
Read on PLOS ONE -
Association of Covid-19 with major arterial and venous thrombotic diseases: A population-wide cohort study of 48 million adults in England and Wales
Read on Circulation, AHA Journals -
Cross-national key performance measures of the quality of acute stroke care in Western Europe
Read on Stroke, AHA Journals -
The economic burden of stroke care in England, Wales and Northern Ireland: Using a national stroke register to estimate and report patient-level health economic outcomes in stroke
Read on Sage Journals -
Socioeconomic disparities in first stroke incidence, quality of care, and survival: a nationwide registry-based cohort study of 44 million adults in England
Read on The Lancet -
Patient outcomes up to 15 years after stroke: survival, disability, quality of life, cognition and mental health
Read on the BMJ's Journal of Neurology, Neurosurgery & Psychiatry -
Estimating the financial cost of chronic kidney disease to the NHS in England
Read on Oxford Academic -
Improving health evaluations to capture wider value of therapeutics and incentivise innovation
Read on PubMed -
Variations in comorbidity burden in people with type 2 diabetes over disease duration: A population-based analysis of real world evidence
Read on The Lancet -
Excess mortality in England post Covid-19 pandemic: implications for secondary prevention
Read on The Lancet -
The impact of the Covid-19 pandemic on cardiovascular disease prevention and corresponding geographical inequalities in England: interrupted time series analysis
Read on PMC -
An insurance value modeling approach that captures the wider value of a novel antimicrobial to health systems, patients, and the population
Read on the Journal of Health Economics and Outcomes Research -
Value-Based Healthcare in practice: IDEATE, a collaboration to design and test an outcomes-based agreement for a medicine in Wales
Read on Research Square -
Emulating trials and quantifying bias: The convergence of health technology assessment agency real-world evidence guidance
Read on Value in Health -
Real world outcomes, healthcare utilisation and costs of Alzheimer's disease in England
Read on ScienceDirect -
-
-
-
Access in all areas? A round up of developments in market access and health technology assessment
Read Part 3 Read Part 4 -
-
First in class, best in class or a wild card: who will dominate the anti-obesity medication market?
Read on Becaris -
Why is target trial emulation not being used in health technology assessment real-world data submissions?
Read on Becaris -
Tackling health inequalities through the development of the wider public health workforce
Read on PubMed -
A review of 25 years of National Institute of Health and Care Excellence decision making
Read on Becaris
Explore more health insights
Filter by
There are no results that match your query.
Please adjust the filters or your search term.
Loading...
Get in touch
Contact us to learn more about how we can bring you clarity and insight in an increasingly complex life sciences and healthcare environment.
